Effect of an herbal supplement containing Cinnamon, Cumin and Phyllanthus emblica ?on inflammatory response in type II diabetes

Phase 2

Recruiting

• Conditions: Type II diabetes.; Diabetes mellitus due to underlying condition

• Registration Number: IRCT20141209020258N142
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Fasting blood sugar is equal to or higher than 126 milligram per millileter
Taking oral hypoglycemic drugs
Consumption of a fixed dose of oral hypoglycemic drugs for at least the last 3 months
Eating bread in the diet and not getting celiac disease
Lack of kidney failure
Lack of type 1 diabetes
Lack of acute and chronic inflammatory diseases
Lack of malignancy
Lack of drug addiction
No pregnancy or lactation

Exclusion Criteria

Dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cytokine TGF-ß. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine TNF?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IFN-?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IL-17. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Number of Treg cells. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Nitric oxide measurement. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.